ABOUT US

ABOUT US

Garonit Pharmaceutical, an American MNC is owned by the brother duo Rohit and Nitin Garg with its head quarter in New Jersey. With a proactive and collaborative approach, a large risk appetite, along with accreditations from giants like Ernst & Young, SAP, and Citibank, Garonit today has a presence worldwide.

We have successfully catered to Fortune 500 companies and small-scale industries in North America , LATAM, EMEA with manufacturing plants located in New Jersey, USA which are cGMP & US-FDA compliant. We also have our warehouse in Germany and the UK. Garonit Pharmaceuticals is one of the few companies in North America to have CEP from EDQM for CHG20%. Garonit Pharmaceuticals offers CHG20% that complies to USP, BP, EP, JP and IP monographs.

Further, Garonit works with clients like UNICEF, WHO, The Red Cross and other iconic philanthropic organisations to make this world a better place . We have our own trust “ Neelam Garg Foundation” through which we support girls’ education for the underprivileged sections of the society

OUR JOURNEY

  • 1994

    Started operations in 1994 with products Triclosan, Hexachloroethane

  • 2000

    Diversified into anti-bacterial and disinfectants: Chlorohexidine salts

  • 2008

    DMF filed for Chlorhexidine Gluconate 20% solution and Chlorhexidine salts

  • 2012

    R N LABORATORIES AFRICA LTD- South Africa

  • 2013

    R N EUROPE- UK - CEP from EDQM for CHG 20%

  • 2016

    R N LABORATORIES AG Switzerland

  • 2017

    GARONIT PHARMACEUTICAL-USA

  • 2018

    R N LABORATORIES HONG KONG BPR from ECHA for CHG 20%

  • 2021

    R N LABORATORIES UK LTD- England

ACCREDITATIONS

Food and Drug Administration

European Directorate for the Quality of Medicines and HealthCare

Environmental Protection Agency